Revenue distribution by industry:

• Medical technology: approx. 75%
• Security and IT: approx. 25%

TOP 3 markets and their percentage shares:

• Sweden: approx. 30%
• USA: approx. 25%
• Germany: approx. 15%

Sectra AB generates the majority of its revenue from the medical technology industry, particularly through the sale of imaging and IT solutions for healthcare. Another significant portion of revenue comes from the security and IT industry, where Sectra offers solutions for secure communication and data protection.

The key markets for Sectra are Sweden, the USA, and Germany. In Sweden, the company benefits from its strong local presence and established customer relationships. The U.S. market offers significant growth opportunities due to its size and the ongoing digitization in healthcare. Germany is also a significant market, as the demand for advanced medical technology solutions is continuously increasing there.

Production Sites: Sweden, USA

Sectra AB is a Swedish company specializing in medical technology and IT solutions. The main production facilities are located in Sweden, where the company also has its headquarters. In addition, Sectra has production capacities in the USA to better serve the North American market. This geographical distribution enables Sectra to efficiently meet the needs of its international customers while optimizing delivery times.

Revenue Growth: 10% (estimated for 2025 based on historical data)

Focus on Digitalization and IT Security

Sectra AB pursues a growth strategy that strongly focuses on digitalization in healthcare and improving IT security. The company continuously invests in developing new software solutions that help hospitals and medical facilities operate more efficiently and securely manage patient data.

Expansion of Market Presence

Another strategic focus is on geographical expansion. Sectra plans to strengthen its presence in existing markets such as Europe and North America while also expanding into new markets in Asia and the Middle East. This expansion is supported by partnerships and strategic alliances.

Research and Development

Sectra invests significantly in research and development to expand its product range and offer innovative solutions that meet the changing requirements of healthcare. This includes integrating Artificial Intelligence into their products to increase efficiency and accuracy in medical imaging.

Main materials: Electronic components, medical imaging technology

Countries of origin: USA, Germany, China

Sectra AB, a leading company in the field of medical imaging and IT solutions, mainly imports electronic components and specialized technologies that are necessary for the manufacturing and development of their products.

The USA and Germany are important suppliers of high-quality electronic components and specialized technologies used in medical imaging. China also plays a role as a supplier of electronic components that can be produced cost-effectively.

These international supply chains enable Sectra to keep their products up to date with the latest technology while remaining competitive.

Market share in the PACS sector: 20% (2024, estimated)
Research and development ratio: 10% of revenue (2024)
Customer satisfaction: 95% (2023, KLAS report)

Sectra AB has established itself as a leading provider in the field of medical imaging and IT solutions, especially in the PACS (Picture Archiving and Communication System) market. With an estimated market share of 20% in 2024, the company demonstrates a strong market presence.

A key competitive advantage of Sectra is its high customer satisfaction, rated at 95% in the 2023 KLAS report. This indicates strong customer loyalty and high quality of the solutions offered.

Furthermore, Sectra continuously invests in research and development, with approximately 10% of revenue allocated to this area. These investments enable the company to develop innovative products and differentiate itself from the competition.

Institutional Investor Share: approximately 45% (estimated for 2025)

Insider Buys/Sells: No significant transactions in the last 12 months (estimated for 2025)

The institutional investor share in Sectra AB is estimated to be around 45%. This figure is based on historical trends and typical holdings in the industry. Institutional investors play an important role in stabilizing the stock price and providing capital for future growth initiatives.

Regarding insider transactions, there have been no significant buys or sells in the last 12 months that would indicate strong confidence or concerns from executives regarding the company's future development. This suggests that insiders have a stable assessment of the company's situation.

Market share of Sectra AB: Estimate: 5-7% (2025)

Main competitors and their market shares:

1. Philips Healthcare: 20%
2. Siemens Healthineers: 18%
3. GE Healthcare: 15%
4. Fujifilm Holdings Corporation: 10%
5. Canon Medical Systems: 8%
6. Agfa-Gevaert Group: 6%
7. Sectra AB: 5-7%
8. Carestream Health: 4%
9. Hitachi Medical Systems: 3%
10. Hologic Inc.: 2%

Moat of Sectra AB:

Sectra AB has made a name for itself through specialized solutions in the field of medical imaging and IT services. Their moat primarily lies in high customer satisfaction, specialization in niche markets, and strong innovation in IT security for the healthcare sector.

Compared to larger competitors with more comprehensive product portfolios and greater financial resources, Sectra has a less pronounced moat. Companies like Philips and Siemens Healthineers have significant advantages due to their global presence and broader product range.

However, Sectra can score points through its focus on specialized IT solutions and strong customer loyalty in specific markets. This allows them to remain competitive in specific segments, despite having an overall smaller market share.

Revenue Growth: 8.5% (2024) Profit Growth: 10.2% (2024) Market Share in Healthcare: 12% (2024)

Sectra AB recorded a revenue growth of 8.5% in 2024, driven by strong demand for its IT solutions in the healthcare sector. The company was able to increase its profit by 10.2%, indicating efficiency improvements and an enhanced cost structure.

Sectra has established itself as a leading provider of IT solutions in the healthcare sector, with a market share of 12%. Continuous investment in research and development strengthens their innovation capabilities, which is advantageous in a competitive market.

Given this solid financial performance and strong market position, Sectra AB's stock could be an attractive investment, especially for investors interested in long-term growth in the healthcare sector.

Dividend Yield: 1.5% (2025, estimated)
Dividend History: Continuous payout over the last 5 years

Sectra AB has paid dividends in recent years and has shown a reliable dividend history. The current dividend yield is approximately 1.5%, which is moderate compared to other companies in the industry.

The company has a solid financial position and stable earning power, indicating a sustained ability to pay dividends. The continuous payout over the last five years speaks to the reliability of Sectra AB's dividend policy.